Skip to main content
Top
Published in: BMC Palliative Care 1/2016

Open Access 01-12-2016 | Research article

How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study

Authors: Jack P. Wang, Chen-Yi Wu, I-Hsuan Hwang, Chien-Hui Kao, Yi-Ping Hung, Shinn-Jang Hwang, Chung-Pin Li

Published in: BMC Palliative Care | Issue 1/2016

Login to get access

Abstract

Background

Inpatient palliative care is important for patients with terminal pancreatic cancer. However, the differences between inpatient palliative care and acute hospital care for inpatients with pancreatic cancer have not been explored in a population-based study.

Methods

This population-based nationwide study was conducted using data from the Taiwan National Health Insurance database to analyze the differences between inpatient palliative care and acute hospital care for inpatients with pancreatic cancer. We identified 854 patients with terminal pancreatic cancer, who had received in-hospital end-of-life care between January 2003 and December 2006. These patients were then sub-divided and matched 1:1 (using propensity score matching) according to whether they received inpatient palliative care (n = 276) or acute hospital care (n = 276). These groups were subsequently compared to evaluate any differences in the use of aggressive procedures, prescribed medications, and medical costs.

Results

Inpatient palliative care was typically provided by family physicians (39 %) and oncologists (25 %), while acute hospital care was typically provided by oncologists (29 %) and gastroenterologists (24 %). The inpatient palliative care group used natural opium alkaloids significantly more frequently than the acute hospital care group (84.4 % vs. 56.5 %, respectively; P < 0.001). The inpatient palliative care group also had shorter hospital stays (10.6 ± 11.1 days vs. 20.6 ± 16.3 days, respectively; P < 0.001), fewer aggressive procedures, and lower medical costs (both, P < 0.005).

Conclusions

Compared to patients in acute hospital wards, patients with pancreatic cancer in inpatient palliative care units received more frequent pain control treatments, underwent fewer aggressive procedures, and incurred lower medical costs. Therefore, inpatient palliative care should be considered a viable option for patients with terminal pancreatic cancer.
Literature
1.
2.
go back to reference Chao Y, Wu CY, Wang JP, Lee RC, Lee WP, Li CP. A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2013;72(3):637–42.CrossRefPubMed Chao Y, Wu CY, Wang JP, Lee RC, Lee WP, Li CP. A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2013;72(3):637–42.CrossRefPubMed
3.
go back to reference Clark D, editor. Cicely Saunders - Founder of the hospice movement : Selected letters 1959-1999. London: Oxford University Press; 2005. Clark D, editor. Cicely Saunders - Founder of the hospice movement : Selected letters 1959-1999. London: Oxford University Press; 2005.
5.
go back to reference Kane RL, Wales J, Bernstein L, Leibowitz A, Kaplan S. A randomised controlled trial of hospice care. Lancet. 1984;1(8382):890–4.CrossRefPubMed Kane RL, Wales J, Bernstein L, Leibowitz A, Kaplan S. A randomised controlled trial of hospice care. Lancet. 1984;1(8382):890–4.CrossRefPubMed
7.
go back to reference Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage. 2007;33(3):238–46.CrossRefPubMed Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage. 2007;33(3):238–46.CrossRefPubMed
8.
go back to reference Tang ST, Chen ML, Huang EW, Koong SL, Lin GL, Hsiao SC. Hospice utilization in Taiwan by cancer patients who died between 2000 and 2004. J Pain Symptom Manage. 2007;33(4):446–53.CrossRefPubMed Tang ST, Chen ML, Huang EW, Koong SL, Lin GL, Hsiao SC. Hospice utilization in Taiwan by cancer patients who died between 2000 and 2004. J Pain Symptom Manage. 2007;33(4):446–53.CrossRefPubMed
9.
go back to reference Tang ST, Huang EW, Liu TW, Wang HM, Chen JS. A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001-2006. Psychooncology. 2010;19(11):1213–20.CrossRefPubMed Tang ST, Huang EW, Liu TW, Wang HM, Chen JS. A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001-2006. Psychooncology. 2010;19(11):1213–20.CrossRefPubMed
10.
go back to reference Tang ST, Liu TW, Lai MS, McCorkle R. Discrepancy in the preferences of place of death between terminally ill cancer patients and their primary family caregivers in Taiwan. Soc Sci Med. 2005;61(7):1560–6.CrossRefPubMed Tang ST, Liu TW, Lai MS, McCorkle R. Discrepancy in the preferences of place of death between terminally ill cancer patients and their primary family caregivers in Taiwan. Soc Sci Med. 2005;61(7):1560–6.CrossRefPubMed
11.
go back to reference Chiou JD, Chen CW, Lin MH, Wu PY, Liu JY, Chen TJ, et al. A five-year analysis of the inpatient service of the hospice and palliative care unit in VGH-Taipei, Taiwan. J Fam Med. 2005;15:123–33. Chiou JD, Chen CW, Lin MH, Wu PY, Liu JY, Chen TJ, et al. A five-year analysis of the inpatient service of the hospice and palliative care unit in VGH-Taipei, Taiwan. J Fam Med. 2005;15:123–33.
14.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
15.
go back to reference D'Agostino Jr RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–81.CrossRefPubMed D'Agostino Jr RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–81.CrossRefPubMed
16.
go back to reference Nelder J, Wedderburn R. Generalized linear models. J R Stat Soc A Stat. 1972;135:370–84.CrossRef Nelder J, Wedderburn R. Generalized linear models. J R Stat Soc A Stat. 1972;135:370–84.CrossRef
17.
go back to reference Hwang SJ, Chang HT, Hwang IH, Wu CY, Yang WH, Li CP. Hospice offers more palliative care but costs less than usual care for terminal geriatric hepatocellular carcinoma patients: a nationwide study. J Palliat Med. 2013;16(7):780–5.CrossRefPubMed Hwang SJ, Chang HT, Hwang IH, Wu CY, Yang WH, Li CP. Hospice offers more palliative care but costs less than usual care for terminal geriatric hepatocellular carcinoma patients: a nationwide study. J Palliat Med. 2013;16(7):780–5.CrossRefPubMed
20.
go back to reference Huo TI, Lin HC, Hsia CY, Wu JC, Lee PC, Chi CW, et al. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol. 2007;102(9):1920–30.CrossRefPubMed Huo TI, Lin HC, Hsia CY, Wu JC, Lee PC, Chi CW, et al. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol. 2007;102(9):1920–30.CrossRefPubMed
21.
go back to reference Beccaro M, Costantini M, Giorgi Rossi P, Miccinesi G, Grimaldi M, Bruzzi P, et al. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC). J Epidemiol Community Health. 2006;60(5):412–6.CrossRefPubMedPubMedCentral Beccaro M, Costantini M, Giorgi Rossi P, Miccinesi G, Grimaldi M, Bruzzi P, et al. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC). J Epidemiol Community Health. 2006;60(5):412–6.CrossRefPubMedPubMedCentral
22.
go back to reference Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3(3):287–300.CrossRefPubMed Higginson IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med. 2000;3(3):287–300.CrossRefPubMed
23.
go back to reference Keating NL, Landrum MB, Rogers Jr SO, Baum SK, Virnig BA, Huskamp HA, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116(4):998–1006.CrossRefPubMedPubMedCentral Keating NL, Landrum MB, Rogers Jr SO, Baum SK, Virnig BA, Huskamp HA, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116(4):998–1006.CrossRefPubMedPubMedCentral
24.
go back to reference Loke SS, Rau KM. Differences between inpatient hospice care and in-hospital nonhospice care for cancer patients. Cancer Nurs. 2011;34(3):E21–26.CrossRefPubMed Loke SS, Rau KM. Differences between inpatient hospice care and in-hospital nonhospice care for cancer patients. Cancer Nurs. 2011;34(3):E21–26.CrossRefPubMed
25.
go back to reference Lin WY, Chiu TY, Hsu HS, Davidson LE, Lin T, Cheng KC, et al. Medical expenditure and family satisfaction between hospice and general care in terminal cancer patients in Taiwan. J Formos Med Assoc. 2009;108(10):794–802.CrossRefPubMed Lin WY, Chiu TY, Hsu HS, Davidson LE, Lin T, Cheng KC, et al. Medical expenditure and family satisfaction between hospice and general care in terminal cancer patients in Taiwan. J Formos Med Assoc. 2009;108(10):794–802.CrossRefPubMed
26.
go back to reference World Health Organization. Cancer pain relief. 2nd ed. Geneva: WHO; 1996. World Health Organization. Cancer pain relief. 2nd ed. Geneva: WHO; 1996.
27.
go back to reference Ramondetta L. What is the appropriate approach to treating women with incurable cervical cancer? J Natl Compr Canc Netw. 2013;11(3):348–55.CrossRefPubMed Ramondetta L. What is the appropriate approach to treating women with incurable cervical cancer? J Natl Compr Canc Netw. 2013;11(3):348–55.CrossRefPubMed
29.
go back to reference Tang ST. Meanings of dying at home for Chinese patients in Taiwan with terminal cancer: a literature review. Cancer Nurs. 2000;23(5):367–70.CrossRefPubMed Tang ST. Meanings of dying at home for Chinese patients in Taiwan with terminal cancer: a literature review. Cancer Nurs. 2000;23(5):367–70.CrossRefPubMed
30.
go back to reference Lo JC. The impact of hospices on health care expenditures--the case of Taiwan. Soc Sci Med. 2002;54(6):981–91.CrossRefPubMed Lo JC. The impact of hospices on health care expenditures--the case of Taiwan. Soc Sci Med. 2002;54(6):981–91.CrossRefPubMed
31.
go back to reference Pyenson B, Connor S, Fitch K, Kinzbrunner B. Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manage. 2004;28(3):200–10.CrossRefPubMed Pyenson B, Connor S, Fitch K, Kinzbrunner B. Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manage. 2004;28(3):200–10.CrossRefPubMed
Metadata
Title
How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study
Authors
Jack P. Wang
Chen-Yi Wu
I-Hsuan Hwang
Chien-Hui Kao
Yi-Ping Hung
Shinn-Jang Hwang
Chung-Pin Li
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2016
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-016-0075-x

Other articles of this Issue 1/2016

BMC Palliative Care 1/2016 Go to the issue